U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 20

1.

Bifidobacterium breve UCC2003 metabolizes lacto-N-tetraose and lacto-N-neo-tetraose through overlapping, yet distinct pathways

(Submitter supplied) Recent studies have begun to elucidate the mechanisms of utilisation of some human milk oligosaccharides (HMO) components by Bifidobacterium breve. However, this phenomenon is still relatively poorly understood, with little to no work to date in understanding a number of specific structures common to HMO.   In this study, we demonstrate that the prototype B. breve strain UCC2003 possesses specific metabolic pathways for the utilisation of Lacto-N-Tetraose and Lacto-N-neoTetraose, which represent the central moieties of Type I and Type II HMOs, respectively. more...
Organism:
Bifidobacterium breve UCC2003
Type:
Expression profiling by array
Platform:
GPL13210
10 Samples
Download data: TXT
Series
Accession:
GSE84710
ID:
200084710
2.

Bifidobacterium breve UCC2003 employs multiple transcriptional regulators in a series of glycan-induced positive feedback loops to regulate HMO metabolism

(Submitter supplied) Regulation of carbohydrate metabolism in Bifidobacterium breve has been studied in detail for a variety of both plant and human-derived glycans, particularly in the model strain UCC2003. We have recently comprehensively elucidated the precise metabolic pathways by which the human milk oligosaccharide (HMO) components LNT, LNnT and LNB are utilized by B. breve UCC2003. However, no work has been carried out to date in identifying and understanding the regulatory mechanisms that control transcription of the genetic loci involved in these metabolic pathways. more...
Organism:
Bifidobacterium breve UCC2003
Type:
Expression profiling by array
Platforms:
GPL24137 GPL24138
8 Samples
Download data: TXT
Series
Accession:
GSE105108
ID:
200105108
3.

Human Milk Oligosaccharide Utilization in Intestinal Bifidobacteria is Governed by Global Transcriptional Regulator NagR

(Submitter supplied) Bifidobacterium longum subsp. infantis (B. infantis) is a prevalent beneficial bacterium that colonizes the human neonatal gut and is uniquely adapted to efficiently use human milk oligosaccharides (HMOs) as a carbon and energy source. Multiple studies have focused on characterizing the elements of HMO utilization machinery in B. infantis; however, the regulatory mechanisms governing the expression of these catabolic pathways remain poorly understood. more...
Organism:
Bifidobacterium longum subsp. infantis
Type:
Expression profiling by high throughput sequencing
Platform:
GPL28926
12 Samples
Download data: TXT
Series
Accession:
GSE196064
ID:
200196064
4.

Identification and characterization of a glycosulfatase-encoding gene cluster in Bifidobacterium breve UCC2003

(Submitter supplied) A bacterial nursling stool isolate, Bifidobacterium breve UCC2003, encodes two putative sulfatases. The sulfated monosaccharide N-acetylglucosamine-6-sulfate (GlcNAc-6-S) was shown to support growth of B. breve UCC2003, while three other tested sulfated monosaccharides, N-acetylglucosamine-3-sulfate, N-acetylgalactosamine-3-sulfate and N-acetylgalactosamine-6-sulfate, did not. Using a combination of transcriptomic and functional genomic approaches, a gene cluster, designated ats2, was shown to be specifically required for GlcNAc-6-S metabolism. more...
Organism:
Bifidobacterium breve UCC2003
Type:
Expression profiling by array
Platform:
GPL8878
4 Samples
Download data: TXT
Series
Accession:
GSE81240
ID:
200081240
5.

Carbohydrate Syntrophy enhances the establishment of Bifidobacterium breve UCC2003 in the neonatal gut

(Submitter supplied) To extend our understanding of bifidobacterial mutualism and carbohydrate syntrophy in the gut we adopted advanced functional genomics to create single- and double-deletion isogenic strains of the NagA encoding genes of B. breve UCC2003. The resulting strains were examined, as compared to the parent strain, for their ability to metabolise particular host derived carbohydrates. In addition, the B. breve strains were examined for their crossfeeding capability and ability to establish, in the presence of B. more...
Organism:
Bifidobacterium breve UCC2003
Type:
Expression profiling by array
Platform:
GPL8878
2 Samples
Download data: TXT
Series
Accession:
GSE110077
ID:
200110077
6.

RNA sequencing of Bifidobacterium longum subsp. longum SC596 in response to various substrates

(Submitter supplied) The purpose of this project was to determine the whole transcriptome response of Bifidobacterium longum subsp. longum SC596 to pooled and individual human milk oligosaccharides (HMO) relative to lactose
Organism:
Bifidobacterium longum
Type:
Expression profiling by high throughput sequencing
Platform:
GPL22529
18 Samples
Download data: TXT
Series
Accession:
GSE87697
ID:
200087697
7.

RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides.

(Submitter supplied) Background: Breastfed human infants are predominantly colonized by bifidobacteria that thrive on human milk oligosaccharides (HMO). The two most predominant species of bifidobacteria in infant feces are Bifidobacterium breve (B. breve) and Bifidobacterium longum subsp. infantis (B. infantis), both avid HMO-consumer strains. Our laboratory has previously shown that B. infantis, when grown on HMO, increase adhesion to intestinal cells and increase the expression of the anti-inflammatory cytokine interleukin-10. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL11154
9 Samples
Download data: XLSX
8.

RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides.

(Submitter supplied) Background: Breastfed human infants are predominantly colonized by bifidobacteria that thrive on human milk oligosaccharides (HMO). The two most predominant species of bifidobacteria in infant feces are Bifidobacterium breve (B. breve) and Bifidobacterium longum subsp. infantis (B. infantis), both avid HMO-consumer strains. Our laboratory has previously shown that B. infantis, when grown on HMO, increase adhesion to intestinal cells and increase the expression of the anti-inflammatory cytokine interleukin-10. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL11154
9 Samples
Download data: XLSX
9.

Bifidobacterium infantis intracellular 2-oxogluturate concentration is inversely related to nitrogen accessibility

(Submitter supplied) Bifidobacterium longum subsp. infantis (B. infantis) resides in the human infant gut and helps with the utilization of human milk-derived nutrient components. While its utilization of various carbohydrate sources has been studied extensively, mechanisms behind utilization of nitrogen components from human milk remain largely unknown. In this study, we present B. infantis growth profiles on the N-containing human milk oligosaccharides (HMO) as nitrogen sources, namely, lacto-N-tetraose (LNT) and lacto-N-neotetraose (LNnT). more...
Organism:
Bifidobacterium longum subsp. infantis
Type:
Expression profiling by high throughput sequencing
Platform:
GPL28926
14 Samples
Download data: CSV, TXT
Series
Accession:
GSE209665
ID:
200209665
10.

Bifidobacterium longum subsp. infantis transcriptomes in response to various nitrogen sources

(Submitter supplied) The purpose of this project was to determine the whole transcriptome response of Bifidobacterium longum subsp. infantis to human milk urea compared to complex nitrogen and L-cysteine.
Organism:
Bifidobacterium longum subsp. infantis
Type:
Expression profiling by high throughput sequencing
Platform:
GPL28926
18 Samples
Download data: TXT
Series
Accession:
GSE155078
ID:
200155078
11.

Global transcriptional landscape and promoter mapping of the gut commensal Bifidobacterium breve UCC2003

(Submitter supplied) The recognition specificity and associated affinity of the RNA polymerase sigma subunit towards its cognate promoter sequence is one of the elements contributing to the modulation of gene expression in bacteria. In the present study we identified and assessed vegetative promoters of the bifidobacterial prototype Bifidobacterium breve UCC2003 employing a combination of tiling array analysis and RNA sequencing. more...
Organism:
Bifidobacterium breve UCC2003
Type:
Expression profiling by genome tiling array
Platform:
GPL23645
2 Samples
Download data: TXT
Series
Accession:
GSE100721
ID:
200100721
12.

RNA sequencing of Bifidobacterium bifidum SC555 in response to various substrates

(Submitter supplied) The purpose of this project was to determine the whole transcriptome response of Bifidobacterium bifidum SC555 to pooled and individual human milk oligosaccharides (HMO) relative to lactose
Organism:
Bifidobacterium bifidum
Type:
Expression profiling by high throughput sequencing
Platform:
GPL18891
20 Samples
Download data: TXT
Series
Accession:
GSE59053
ID:
200059053
13.

RNA sequencing of Bifidobacterium longum subsp. infantis in response to various substrates

(Submitter supplied) The purpose of this project was to determine the whole transcriptome response of Bifidobacterium longum subsp. Infantis to pooled and individual human milk oligosaccharides (HMO) relative to lactose
Organism:
Bifidobacterium longum subsp. infantis ATCC 15697 = JCM 1222 = DSM 20088
Type:
Expression profiling by high throughput sequencing
Platform:
GPL18859
18 Samples
Download data: TXT
Series
Accession:
GSE58773
ID:
200058773
14.

Metabolism of four α-glycosidic linkage-containing oligosaccharides by Bifidobacterium breve UCC2003

(Submitter supplied) Members of the genus Bifidobacterium are common inhabitants of the gastrointestinal tract of humans and other mammals, where they ferment many diet-derived carbohydrates that cannot be digested by their host. To extend our understanding of bifidobacterial carbohydrate utilisation, we investigated the molecular mechanisms by which various strains of Bifidobacterium breve metabolize four distinct α-glucose and/or α-galactose-containing oligosaccharides, namely raffinose, stachyose, melibiose and melezitose. more...
Organism:
Bifidobacterium breve UCC2003; Bifidobacterium breve
Type:
Expression profiling by array
Platform:
GPL8878
6 Samples
Download data: TXT
Series
Accession:
GSE47448
ID:
200047448
15.

Cross-feeding by Bifidobacterium breve UCC2003 during Bifidobacterium bifidum PRL2010 growth on a mucin-based medium.

(Submitter supplied) Bifidobacteria constitute commensal bacteria that commonly inhabit the mammalian gastro intestinal tract. The gut commensal Bifidobacterium breve UCC2003 was previously shown to utilise a variety of plant/diet-derived carbohydrates, including cellodextrin, starch and galactan. In the current study, we investigated the ability of this strain to utilize (parts of) a host-derived source of carbohydrate, namely the mucin glycoprotein. more...
Organism:
Bifidobacterium breve UCC2003
Type:
Expression profiling by array
Platform:
GPL8878
1 Sample
Download data: TXT
Series
Accession:
GSE59013
ID:
200059013
16.

Metabolism of sialic acid by Bifidobacterium breve UCC2003

(Submitter supplied) Bifidobacteria constitute a specific group of commensal bacteria which inhabit the gastrointestinal tract of humans and other mammals. Bifidobacterium breve UCC2003 has previously been shown to utilise several plant-derived carbohydrates that include cellodextrins, starch and galactan. In the current study, we investigate the ability of this strain to utilise the mucin- and human milk oligosaccharide (HMO)-derived carbohydrate, sialic acid. more...
Organism:
Bifidobacterium breve UCC2003
Type:
Expression profiling by array
Platform:
GPL8878
2 Samples
Download data: TXT
Series
Accession:
GSE56291
ID:
200056291
17.

Global control of carbon flux in Bifidobacterium breve UCC2003

(Submitter supplied) In this paper, two predicted lac I type transcription factors (TFs) were characterised and shown to be involved in the regulation of the central metabolic pathways of B. breve UCC2003. Although, genetically different, these TF were functionally very similar. When first identified these TFs were named AraQ and MalR1, due to their predicted associations with arabinose and maltose metabolism, respectively. more...
Organism:
Bifidobacterium breve UCC2003
Type:
Expression profiling by array
Platform:
GPL13210
4 Samples
Download data: TXT
Series
Accession:
GSE108949
ID:
200108949
18.

Pan-genome and methylome analysis reveals the diversity of restriction/modification systems in the gut commensal Bifidobacterium breve.

(Submitter supplied) Bifidobacterium breve represents one of the most abundant (bifido)bacterial species in the gastro-intestinal tract of (breast-fed) infants, where their presence is believed to be beneficial. In the present study whole genome sequencing, employing PacBio’s Single Molecule, Real-Time (SMRT) sequencing platform, combined with comparative genome analysis allowed the most extensive genetic investigation of this taxon. more...
Organism:
Bifidobacterium breve; Bifidobacterium breve UCC2003
Type:
Genome variation profiling by array
Platforms:
GPL8878 GPL13210
66 Samples
Download data: TXT
Series
Accession:
GSE104927
ID:
200104927
19.

Functional genome analysis of Bifidobacterium breve UCC2003 reveals a major conserved host-colonization factor

(Submitter supplied) Development of the human gut microbiota commences at birth with bifidobacteria being among the first colonizers of the sterile newborn gastrointestinal tract. To date the genetic basis of bifidobacterial colonization and persistence remains poorly understood. Transcriptomic analysis of the 2,422,684 bp genome of Bifidobacterium breve UCC2003, a strain isolated from a nursling stool, during colonization of a mouse model revealed the differential expression of a type IVb or so-called Tad pilus-encoding cluster. more...
Organism:
Mus musculus; Bifidobacterium breve UCC2003; Bifidobacterium breve
Type:
Expression profiling by array; Genome variation profiling by array
Platforms:
GPL13210 GPL8878
21 Samples
Download data: TXT
Series
Accession:
GSE27491
ID:
200027491
20.

Bile-inducible membrane protein mediates the bile resistance phenotype of Bifidobacterium breve UCC2003

(Submitter supplied) Bbr_0838 from Bifidobacterium breve UCC2003 encodes a 683 residue membrane protein, that contains a permease domain displaying similarity to transporters belonging to the major facilitator superfamily, as well as a CBS (cystathionine beta synthase) domain. The high level of similarity to bile-efflux pumps from other bifidobacteria, suggests a significant role for Bbr_0838 in bile tolerance of B. breve UCC2003. more...
Organism:
Bifidobacterium breve UCC2003
Type:
Expression profiling by array
Platform:
GPL8878
5 Samples
Download data: TXT
Series
Accession:
GSE31224
ID:
200031224
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=1|qty=9|blobid=MCID_677d52330bdf8a6e73358a70|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center